Literature DB >> 19774635

Long-term population-based divorce rates among adult survivors of childhood cancer in Britain.

Clare Frobisher1, Emma R Lancashire, David L Winter, Aliki J Taylor, Raoul C Reulen, Michael M Hawkins.   

Abstract

BACKGROUND: Previously from the British Childhood Cancer Survivor Study (BCCSS) it was seen that adult survivors of childhood cancer were less likely to marry than the general population. The objectives of this study were to assess the number of childhood cancer survivors from the BCCSS who were currently divorced or separated, examine factors associated with marriage dissolution and compare survivor divorce rates to population rates. PROCEDURE: The BCCSS is a population-based cohort of 18,119 individuals diagnosed with cancer aged 0-14 years between 1940 and 1991, and survived at least 5 years. 14,539 were alive, aged 16 years or over and eligible to receive a questionnaire, which ascertained marital status.
RESULTS: From 8,155 survivors, who were aged at least 20 years at questionnaire completion, the proportions currently divorced and divorced or separated were 13.5% and 18.1%, respectively. Only current age, educational attainment and age at marriage were associated with divorce, and for divorce and separation status only age at marriage (P < 0.05). Overall the survivors were no different to the general population for being currently divorced (odds ratio (OR) (95% confidence intervals (95% CI)): 0.94 (0.81-1.10)). However, the survivors overall (OR (95% CI): 0.82 (0.72-0.94)), and separately for those diagnosed with non-Hodgkin lymphoma (OR (95% CI): 0.55 (0.34-0.89)) and leukaemia (OR (95% CI): 0.70 (0.52-0.95)), were less likely to be currently divorced or separated than the general population.
CONCLUSIONS: It is reassuring that survivors do not experience more divorce than the general population, and that no cancer or treatment factors were shown to be associated with marriage dissolution. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 19774635     DOI: 10.1002/pbc.22290

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  7 in total

1.  Life beyond the disease: relationships, parenting, and quality of life among survivors of childhood cancer.

Authors:  Andrew C Dietz; Daniel A Mulrooney
Journal:  Haematologica       Date:  2011-05       Impact factor: 9.941

Review 2.  Social adjustment across the lifespan in survivors of pediatric acute lymphoblastic leukemia (ALL): a systematic review.

Authors:  Sara Cho; Courtney Tromburg; Caitlin Forbes; Andrew Tran; Elleine Allapitan; Taryn Fay-McClymont; Kathleen Reynolds; Fiona Schulte
Journal:  J Cancer Surviv       Date:  2022-01-06       Impact factor: 4.442

Review 3.  Long-term Survivors of Childhood Brain Tumors: Impact on General Health and Quality of Life.

Authors:  Priyamvada Gupta; Rakesh Jalali
Journal:  Curr Neurol Neurosci Rep       Date:  2017-11-08       Impact factor: 5.081

Review 4.  Survivors of childhood and adolescent cancer: life-long risks and responsibilities.

Authors:  Leslie L Robison; Melissa M Hudson
Journal:  Nat Rev Cancer       Date:  2013-12-05       Impact factor: 60.716

5.  Marriage and divorce among young adult cancer survivors.

Authors:  Anne C Kirchhoff; Jaehee Yi; Jennifer Wright; Echo L Warner; Ken R Smith
Journal:  J Cancer Surviv       Date:  2012-09-06       Impact factor: 4.442

6.  No evidence of response bias in a population-based childhood cancer survivor questionnaire survey - Results from the Swiss Childhood Cancer Survivor Study.

Authors:  Corina S Rueegg; Micòl E Gianinazzi; Gisela Michel; Marcel Zwahlen; Nicolas X von der Weid; Claudia E Kuehni
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

7.  Family size and duration of fertility in female cancer survivors: a population-based analysis.

Authors:  Richard A Anderson; Tom W Kelsey; David S Morrison; W Hamish B Wallace
Journal:  Fertil Steril       Date:  2021-12-20       Impact factor: 7.329

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.